Advertisement

Topics

Companies Related to "Immunoassay Biomarkers Evaluated Preeclampsia Diagnosis" [Most Relevant Company Matches] RSS

02:06 EDT 25th June 2018 | BioPortfolio

Here are the most relevant search results for "Immunoassay Biomarkers Evaluated Preeclampsia Diagnosis" found in our extensive corporate database of over 50,000 company records.

Showing "Immunoassay Biomarkers Evaluated Preeclampsia Diagnosis" Companies 1–25 of 810

Extremely Relevant

Carmenta Bioscience, Inc.

Carmenta Bioscience is a privately held, medical technology company focused on advancing maternal and fetal health by applying a systems biology approach to the diagnosis and prediction of preeclampsia. Carmenta’s products in development combine proprietary computational algorithms with novel serum protein measurements to classify pregnant mothers at ...


Relevant

Molecular Biometrics, LLC

Metabolomics is a complex scientific process that identifies and measures individual signals from many small molecular compounds produced by cellular metabolism which, when evaluated as a whole, represent unique biomarkers of biologic function in health and disease.

Singulex, Inc

Singulex pioneered technology that can quantitatively detect single molecules such as proteins and metabolites in complex biological samples. Our patented technology extends the dynamic range of any immunoassay by orders of magnitude, allowing drug developers to use biomarkers to measure drug efficacy, safety and disease progression. In addition, our technology is applicable to the diagnostics mar...


Banyan Biomarkers, Inc.

Banyan Biomarkers is the leader in developing in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury. The Company is focused on developing a simple point-of-care blood test that will be used by physicians to detect the presence and severity of brain trauma and improve the medical management of head i...

CD Diagnostics, Inc.

CD Diagnostics (www.cddiagnostics.com) is developing a series of immunoassays to detect the cause of joint pain using joint fluid analysis. The assays use a small sample of a patient’s joint fluid (called synovial fluid) to measure the presence of proteins (also known as biomarkers) that are produced by the body and are specific to a particular joint ...

Astute Medical, Inc.

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. The Company's current areas of interest include abdominal ...

Amplion Inc.

Amplion publishes BiomarkerBase™ (http://www.biomarkerbase.com), the most complete database of biomarkers in clinical use and development. BiomarkerBase™ includes every biomarker used in and FDA-approved test or drug label, and thousands of biomarkers being used and developed in clinical trials. Many of the world’s leading diagnostics and bi...

ImmunArray

Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The company designs and analyzes sets of biomarkers known to be linked to a part...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac and critical care diagnostics.Innotrac Diagnostics has proven expertise in immunoassay system development (chemistry, hardware and software).Innotrac is a proven supplier of contract manufacturing ser...

Journal of Maternal-Fetal & Neonatal Medicine

"Left untreated, preeclampsia leads to serious - or fatal - complications for both the mother and baby," says Dr Kusanovic of the Perinatology Research Branch of the NIH and Wayne State University/Hutzel Women's Hospital in Detroit, Michigan and lead author of the study.

Vivomicx

We identify: real biomarkers for drug efficacy to speed up your development process Using this, you can relate true molecular effects to disease activity and the value of your biomarkers We Validate: the pharmacological identity of your NME in complex tissues in vivo, before your drug enters clinical testing the expression of your new putative targets in patient materials your biomarkers...

Oxford Biomedical Research, Inc.

Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company’s primary focus is on the identification and assay of biomarkers for oxidative stress and chronic inflammation, two major risk factors for multiple diseases. OBR is employing proprietary technology to develop tissue and diseas...

Biohedron.Inc.

Visualizing Protein Complexes• A Pair of Polyhedra• Surface Buried in an Interface• Computing a Surface Between Two Densities• Polyhedra Evaluated at an Interfacial Surface• Densities Evaluated at an Interfacial Surface

Stemina Biomarker Discovery Inc.

Stemina Biomarker Discovery was founded in 2007 and is located in Madison, Wisconsin. Stemina is a biomarker discovery company focused on diagnosis and individualized treatment of neurological disorders including autism spectrum disorders. Stemina uses its proprietary metabolomics platform to identify changes in metabolism that can be biomarkers more effec...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics (www.criticaldiagnostics.com) develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs. The Presage ST2 Assay has been CE Marked and cleared by the US FDA. Critical Diagnostics has exclusive worldwide rights to ST2 for the diagnosis and prognosis of cardiovascular ...

OXIS International

OXIS International, Inc. develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress associated with damage from free radical and reactive oxygen species.The company holds the rights to three therapeutic classes of compounds in the area of oxidative stress, and has focused commercialization programs in clinical cardiovascular markers, including MPO (mye...

NeuroPointDX

NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. ...

Singulex, Inc.

Singulex, Inc. helps manage patient health risks by answering critical health questions about disease and therapeutic intervention utilizing cutting edge immunodiagnostic products. Singulex has pioneered technology that can quantitatively detect single molecules, including proteins and metabolites, in complex biological samples. The technology embedded in ...

Isabel Healthcare

Isabel Healthcare provides tools for Diagnosis Decision Support Solutions that address the recognized diagnosis error problem, seamlessly integrate into clinical workflow, and complement a physician’s knowledge during the diagnosis process. Contact us at info@isabelhealthcare.com or 734-332-0612.

Amplion Research

Amplion Research develops novel information solutions that support investments in biomarker discovery, development and commercialization. BiomarkerBase™ is the company’s first product, and future products include Emerging Biomarkers™, a trend analysis tool for newly discovered and developing biomarkers, plus multiple syndicated research reports. ...

Singulex Inc.

Singulex develops and commercializes innovative technology solutions that enable disease understanding and management for life science researchers and clinicians. Utilizing proprietary quantitative single molecule detection technology, Singulex develops customized biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers in a variety of biological samples...

Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the Assay Designs and Stressgen(R) brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and c...

Labmaster Oy

We focus on delivering innovative diagnostic tools for applications in functional food research and routine clinical diagnostics.The technologies used in products include robust enzyme ligand immunoassay (ELISA), sensitive and robust time-resolved fluorescence immunoassay (TR-FIA) and PCR-based diagnostics. The products are used in functional foods research, routine diagnostics of coeliac diseases...

Biolinq Incorporated

Biolinq is a digital health company developing a skin-applied, minimally-invasive electrochemical biosensor platform which analyzes biomarkers in the interstitial fluid to provide actionable health information. Given the platform potential of the technology and the unique ability to simultaneously measure multiple biomarkers, the company aims to develop a ...

EnviroLogix

Founded in 1996 by a group of experienced immunoassay diagnostic test kit developers, EnviroLogix has built on its strong scientific foundation to become an industry leader in the development and manufacture of immunoassay test kits for every link in the worldwide food production chain, from seed to plant to grain handling and processing.At EnviroLogix, we’re committed to providing the most inno...


More From BioPortfolio on "Immunoassay Biomarkers Evaluated Preeclampsia Diagnosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks